ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,564Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 680

$883K Total Retail Price of All Prescriptions

Rank: 110 out of 680

527 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 527 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

28% of this provider’s 527 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 13,378 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 917 708 S3 1 4
AMLODIPINE BESYLATE 826 739 2 1
BENAZEPRIL HCL 467 427 3 40
OMEPRAZOLE 415 336 4 7
SIMVASTATIN 395 349 5 3
LEVOTHYROXINE SODIUM 330 287 6 2
METFORMIN HCL 323 261 7 8
TRAMADOL HCL 318 287 8 18
CARVEDILOL 311 304 9 23
NEXIUM 295 211 10 16
ZOLPIDEM TARTRATE 285 184 11 17
HYDROCHLOROTHIAZIDE 254 218 12 9
METOPROLOL TARTRATE 240 215 13 12
CITALOPRAM HBR 232 181 14 22
TRAZODONE HCL 227 162 15 48
FUROSEMIDE 223 198 16 6
LISINOPRIL 219 198 17 5
MELOXICAM 193 183 18 24
FLUTICASONE PROPIONATE 192 149 19 41
GABAPENTIN 153 128 20 15
POLYETHYLENE GLYCOL 3350 152 126 21 62
CYMBALTA 149 115 22 46
POTASSIUM CHLORIDE 136 113 23 14
BUSPIRONE HCL 132 103 24 144
FENTANYL 131 106 S2 25 183
WARFARIN SODIUM 130 99 26 20
ROPINIROLE HCL 129 106 27 99
ENALAPRIL MALEATE 124 112 28 65
AMLODIPINE BESYLATE-BENAZEPRIL 120 97 29 43
AMITRIPTYLINE HCL 113 101 R 30 47
LOVASTATIN 112 91 31 44
PREMARIN 109 97 R 32 105
VENLAFAXINE HCL ER 108 74 33 101
QUETIAPINE FUMARATE 106 64 34 64
IPRATROPIUM BROMIDE 105 101 35 211
ESCITALOPRAM OXALATE 104 98 36 45
ALENDRONATE SODIUM 103 68 37 32
METOPROLOL SUCCINATE 100 77 38 13
NABUMETONE 98 86 39 174
DIOVAN 98 85 39 31
ALPRAZOLAM 95 80 41 72
ESTRADIOL 95 84 R 41 134
CLOPIDOGREL 94 92 43 26
SYNTHROID 93 86 44 38
CARISOPRODOL 93 23 R 44 83
JANUVIA 92 92 46 60
MORPHINE SULFATE ER 91 54 S2 47 198
ENABLEX 88 88 48 217
GLIPIZIDE XL 87 79 49 142
GLIMEPIRIDE 87 75 49 29
PRAVASTATIN SODIUM 87 75 49 10
RANITIDINE HCL 86 53 52 56
SPIRIVA 84 83 53 70
PREDNISONE 80 45 54 50
TAMSULOSIN HCL 80 80 54 34
MIRTAZAPINE 77 77 56 78
PLAVIX 76 72 57 39
CLONIDINE HCL 76 58 57 36
ATORVASTATIN CALCIUM 76 71 57 11
PANTOPRAZOLE SODIUM 73 45 60 30
GLIPIZIDE 72 53 61 63
MEGESTROL ACETATE 72 42 R 61 88
CRESTOR 71 22 63 25
METOCLOPRAMIDE HCL 68 42 64 118
CELEBREX 68 42 64 90
ADVAIR DISKUS 68 57 64 53
PAROXETINE HCL 67 67 67 76
CHLORTHALIDONE 66 58 68 192
PROAIR HFA 64 41 69 67
CIPROFLOXACIN HCL 63 51 70 57
PRIMIDONE 62 48 71 382
FAMOTIDINE 60 60 72 89
NAMENDA 59 59 73 35
METHYLPREDNISOLONE 58 48 74 93
DOXEPIN HCL 58 32 74 200
AZITHROMYCIN 58 41 74 42
LANTUS 57 34 77 49
FLUOXETINE HCL 56 24 78 74
SERTRALINE HCL 55 41 79 28
GLIPIZIDE ER 55 29 79 108
LOSARTAN POTASSIUM 55 45 79 21
TRIAMTERENE-HCTZ 53 53 82 52
LABETALOL HCL 52 31 83 158
BUPROPION HCL SR 52 44 83 250
OXYCODONE HCL 51 36 S2 85 187
LEVOFLOXACIN 51 43 85 97
SEROQUEL 50 27 87 123
SINGULAIR 50 21 87 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.